Sundhed og Træning
Slagelse, Region Sjælland, 4200, Denmark
NCT Number: NCT04862481
When choosing outcomes to assess rehabilitation's effect or progress, it is essential to consider the constructs being measured and their value to the patient and the psychometric properties. Choosing an outcome that reflects all aspects of International Classification levels of Functioning, Disability and Health (ICF) is challenging, especially in heterogeneous groups. However, it is important to know the psychometric properties as this gives important knowledge on how to interpret results and, consequently, how this can inform the patient's care. The Short Musculoskeletal Function Assessment (SMFA) questionnaire can reflect differences in patients' functional status with a broad range of disorders, like for elderly citizens undergoing municipality-based rehabilitation. Nevertheless, since there is no golden standard to measure rehabilitation outcomes, construct validity needs to be established to investigate how scores of SMFA can be related to measures on all levels of ICF.
Therefore, this study has three main objectives:
1. To investigate how scores of the SMFA questionnaire are related to measures on different ICF levels 2. To describe the characteristics of older citizens starting municipality-based rehabilitation on all ICF levels 3. To investigate predictor variables of upper- and lower extremity strength
Looking for future studies?
Notify Me65 year and older
All sexes
Observational
Slagelse, Region Sjælland, 4200, Denmark
The present study is a sub-study to the Randomized Controlled Trial (NCT04091308).
The present study aims to include 115 participants who will undergo measures specified in the "Outcome" section. The principal investigator of the study will conduct the testing.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
All citizens that are referred to the health/rehabilitation center aged ≥ 65 years from Slagelse municipality will be invited to a screening interview with a physiotherapist after which the participant will be asked to join the study if not subject to one of the following exclusion criteria's:
Exclusion criteria
Time frame: Baseline
Self reported
Time frame: Baseline
The SF-36 is a generic questionnaire that measures health-related quality of life in the past four weeks. The questionnaire consists of 36 questions which are divided into eight sub-scales and summarized in two sum scores. Higher scores indicate better health status.
Time frame: Baseline
The New Mobility Score assesses the patient's walking function inside, outside, and during shopping. Including whether a walking aid is used. The NMS provides a composed score of the participants' mobility. Each question is scored between 0-3 points, depending on the degree of help. The total possible score is between 0 and 9 points.
Time frame: Baseline
The PRISMA-7 questionnaire is composed of seven items and is used to indicate frailty among participants - each question scores either 0 or 1 points. The total possible score is between 0 and 7 points.
Time frame: Baseline
The Tilburg Frailty Scale is a questionnaire with a bio-psycho-social approach, which measures frailty. It is composed of 15 multidimensional questions, regarding the physical, psychological, and social aspects of human functioning.
Scoring range is between 0-15 points.
Time frame: Baseline
A survey with self-formulated questions regarding name, sex, personal ID (CPR number), educational level, the region of pain the last three months (marked on a body chart), pain intensity and pain duration at the most painful body region the last three months, and physical activity level will also be collected.
Time frame: Baseline
Weight will be measured in kilograms
Time frame: Baseline
Height will be measured in meters
Time frame: Baseline
Systolic and diastolic blood pressure (mmHg) will be measured using the Omron HBP 1100 blood pressure and resting heart rate monitor.
Time frame: Baseline
Resting heart rate (in beats per minute) will be measured using the Omron HBP 1100 blood pressure and resting heart rate monitor.
Time frame: Baseline
The electrical bioimpedance device used in the present study to measure changes in body composition is the "Tanita 9MC-780U Multi Frequency Segmental Body Composition Analyzer". Lean body mass will be measured in kilograms.
Time frame: Baseline
The electrical bioimpedance device used in the present study to measure changes in body composition is the "Tanita 9MC-780U Multi Frequency Segmental Body Composition Analyzer". Lean body mass will be measured in kilograms.
Fat percentage will be measured as a percentage of the total body mass.
Time frame: Baseline
The electrical bioimpedance device used in the present study to measure changes in body composition is the "Tanita 9MC-780U Multi Frequency Segmental Body Composition Analyzer". Lean body mass will be measured in kilograms.
Total body water will be measured as percentage of the total body mass.
Time frame: Baseline
The electrical bioimpedance device used in the present study to measure changes in body composition is the "Tanita 9MC-780U Multi Frequency Segmental Body Composition Analyzer". Lean body mass will be measured in kilograms.
Visceral fat will be measured on a scale ranging between 1-59. Scores above 12 indicate an unhealthy level of visceral fat.
Time frame: Baseline
BMR will be estimated by a bioelectrical impedance analysis device "Tanita 9MC-780U Multi Frequency Segmental Body Composition Analyze" in kilojoules.
Time frame: Baseline
The circumference of the waist (in centimeters) will be divided with the circumference of the hip (in centimeters) to report the Waist-to-hip ratio.
Time frame: Baseline
A maximal isometric voluntary contraction (in newtons) for knee extension will be performed using a strain gauge.
Time frame: Baseline
The handgrip strength (in kilograms) will be measured using a hydraulic handgrip dynamometer (SAEHAN).
Time frame: Baseline
The shoulder abduction strength (in kilograms) will be measured using a handheld dynamometer.
Time frame: Baseline
The elbow flexion and extension strength (in kilograms) will be measured using a handheld dynamometer.
Time frame: Baseline
Five repetitions maximum (RM) strength tests will be performed in the leg press (in kilograms) to calculate one RM.
Time frame: Baseline
Five repetitions maximum (RM) strength tests will be performed in knee extension (in kilograms) to calculate one RM.
Time frame: Baseline
Five repetitions maximum (RM) strength tests will be performed in the calf extension (in kilograms) to calculate one RM
Time frame: Baseline
The 2MWT will measure the distance (in meters) a person can walk in two minutes. Gaits speed will be calculated by dividing the covered distance with the time (two minutes).
Time frame: Baseline
Heart rate (in BPM) will be measured (using the Apple Watch serie 5) before and right after the 2MWT.
Time frame: Baseline
The Borg Rating of Perceived Exertion 6-20 scale will be used to estimate the activity intensity before and right after the 2MWT. Higher numbers indicate higher exertion.
Time frame: Baseline
Time is noted (in seconds) on how long it takes to get up from a chair, walk three meters, turn around and go back to the chair and sit down again.
Time frame: Baseline
A measure of static balance will be performed using a Tandem test. The participants will be tested in three positions for ten seconds each (feet together, semi tandem and full tandem). Time is noted (in seconds) for how long the participant can stand in each position
Time frame: Baseline
Measures for balance and reaction time will be collected using the "Fysiometer," and the protocols within the "Fysiometer" software will be followed.
Time frame: Baseline
Protein and energy intake will be estimated based on 24-hour dietary recall interviews.
University College Absalon
Other
Older Citizens During Municipality-based Rehabilitation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07726498
Aging, Asthenia
Leicester, United Kingdom
View Trial DetailsNCT07275177
Age-Related Loss of Skeletal Muscle Mass, Aging
Miahuatlán de Porfirio Díaz, Oaxaca, Mexico
View Trial DetailsNCT06556706
Aging, Atrophy
Montreal, Canada
View Trial DetailsNCT03707145
Aging, Atrophy
Aberystwyth, Ceredigion, United Kingdom
View Trial Details